Re: Dec 22
|
4
|
Resverlogix Corp.
|
Nov 10, 2020 07:02PM
|
Re: To Be or Not to Be?
|
4
|
Resverlogix Corp.
|
Aug 19, 2021 10:33AM
|
Question
|
4
|
Resverlogix Corp.
|
Feb 23, 2021 01:37PM
|
Critique rvx-208 Science
|
4
|
Resverlogix Corp.
|
Nov 25, 2015 10:44AM
|
Re: Rough Transcript - RVX Confernce Call - 02/04/2021
|
4
|
Resverlogix Corp.
|
Feb 12, 2021 01:39PM
|
Don's discount
|
4
|
Resverlogix Corp.
|
Feb 04, 2018 04:07PM
|
Re: I second that train of thought !!!
|
4
|
Resverlogix Corp.
|
Dec 01, 2015 03:54PM
|
Re: Liquidity
|
4
|
Zenith Epigenetics
|
Jan 24, 2016 11:53AM
|
Re: Don's discount
|
4
|
Resverlogix Corp.
|
Feb 04, 2018 06:10PM
|
Re: Form 45-106F1 Report of Exempt Distribution Dec 13, 2021
|
4
|
Resverlogix Corp.
|
Dec 14, 2021 09:34AM
|
Re: Zenith Epigenetics Announces Initiation of a Phase 2b Triple Negative Breast Cancer (TNBC) Clinical Trial
|
4
|
Zenith Epigenetics
|
Jun 23, 2022 10:59AM
|
Re: Tax Loss Value and Sticking it out
|
4
|
Resverlogix Corp.
|
Oct 06, 2019 08:51PM
|
Re: Management change at Resverlogix
|
4
|
Resverlogix Corp.
|
Jul 06, 2021 08:56AM
|
Re: 3rd party rumour ..
|
4
|
Resverlogix Corp.
|
Nov 26, 2020 04:37PM
|
Re: Teflon Don
|
4
|
Zenith Epigenetics
|
Nov 02, 2022 11:21AM
|
Re: Idea for Zenith
|
4
|
Zenith Epigenetics
|
Jul 14, 2021 11:48AM
|
Re: ... unfinished business
|
4
|
Zenith Epigenetics
|
Oct 25, 2018 11:38AM
|
Easter
|
4
|
Resverlogix Corp.
|
Apr 01, 2021 04:32PM
|
Re: A few thoughts
|
4
|
Resverlogix Corp.
|
Oct 02, 2015 10:07AM
|
Re: Clarification on BETonMACE baseline data
|
4
|
Resverlogix Corp.
|
Sep 09, 2019 05:18PM
|